Stocks · Health care · Pharmaceutical Preparations

ROCKET PHARMACEUTICALS, INC.

RCKT Clue Score36
United States Fiscal year ends December CIK 0001281895 Results filed 10 Aug 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Elisabeth Bjork
2 Jan 2026
Director
Buy
10,000
$3.44
$34.40K
Elisabeth Bjork
27 Aug 2025
Director
Buy
10,000
$3.41
$34.10K
Gaurav Shah
10 Apr 2025
CEO
Buy
20,000
$5.08
$101.60K
Kinnari Patel
9 Apr 2025
See Remarks
Buy indirect
21,099
$4.70
$99.17K
Rtw Investments, LP
6 Oct 2022
Director
Buy indirect
1,355,932
$14.75
$20.00M
Gaurav Shah
7 Feb 2022
CEO
Buy
22,000
$17.34
$381.51K
Rtw Investments, LP
10 Dec 2020
Director
Buy indirect
247,720
$56.00
$13.87M
Kinnari Patel
18 Mar 2020
Chief Operating Officer
Buy indirect
1,000
$9.50
$9.50K
Rtw Investments, LP
10 Dec 2019
Director
Buy indirect
225,000
$22.25
$5.01M
Rtw Investments, LP
16 Apr 2019
Director
Buy indirect
550,005
$17.50
$9.63M
Kinnari Patel
6 Dec 2018
Chief Operating Officer
Buy indirect
5,675
$14.98
$85.01K
David P Southwell
6 Jan 2017
President and CEO
Buy
60,000
$1.75
$105.00K

What was left out

Form 4 filings counted 306
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 18
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 114
Transactions with no price 0
Shares from compensation/vesting 17,342,953
Sales filed before the plan box existed 17
History held since 25 Feb 2015